Fig. 3From: Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studiesForest plot of the odds ratio of leukemia associated with cisplatin- versus non-cisplatin-based chemotherapyBack to article page